Sunflower's 2026 semi-annual report disclosed on August 27 shows that the company achieved operating revenue of 109 million yuan in the first half of the year, down 24.82% year on year. Net profit attributable to the parent company was a loss of 12.3965 million yuan, swinging from profit to loss year on year and plummeting 1,168.07%. Net profit attributable to the parent company after deducting non-recurring items was a loss of 8.7199 million yuan, plunging 19,561.37% year on year. Net cash flow from operating activities was negative 17.51 million yuan, turning from positive to negative year on year, a decline of 308.37%. The company's main business focuses on the pharmaceutical sector, with main operating revenue consisting of active pharmaceutical ingredients and finished formulations. Sales revenue from active pharmaceutical ingredients fell 26.19% year on year, and sales revenue from finished formulations fell 25.71% year on year, with both core businesses shrinking by more than a quarter. The main factors affecting net profit attributable to the parent company include a decline in main business revenue, a credit impairment loss provision on an investment intention payment to Shanghai Xipu Technology Co., Ltd., as well as payment of an administrative penalty imposed by the Zhejiang Bureau of the China Securities Regulatory Commission, a provision for estimated liabilities from pending litigation, and recognition of compensation losses from concluded litigation. In addition, the book value of inventory increased from 171 million yuan at the beginning of the period to 193 million yuan, up 12.9%, while research and development investment fell sharply by 42.67% year on year to 6.457 million yuan. As of August 27, the company's share price closed at 3.11 yuan per share, with a cumulative decline of 49.27% for the year, already halved.
Zhejiang Sunflower Light EnergySwung to a first-half net loss of 12.4 million yuan, down 1,168% YoY, with revenue falling 24.82%.
Sunflower took a credit impairment loss provision on an investment intention payment to Shanghai Xipu Technology.
